Articles with public access mandates - Torben PlesnerLearn more
Available somewhere: 9
Daratumumab plus lenalidomide and dexamethasone for untreated myeloma
T Facon, S Kumar, T Plesner, RZ Orlowski, P Moreau, N Bahlis, S Basu, ...
New England Journal of Medicine 380 (22), 2104-2115, 2019
Mandates: US National Institutes of Health
Monocytes and granulocytes reduce CD38 expression levels on myeloma cells in patients treated with daratumumab
J Krejcik, KA Frerichs, IS Nijhof, B van Kessel, JF van Velzen, AC Bloem, ...
Clinical cancer research 23 (24), 7498-7511, 2017
Mandates: US National Institutes of Health
Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group
J Hillengass, LA Moulopoulos, S Delorme, V Koutoulidis, J Mosebach, ...
Blood cancer journal 7 (8), e599-e599, 2017
Mandates: US National Institutes of Health
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
T Facon, G Cook, SZ Usmani, C Hulin, S Kumar, T Plesner, C Touzeau, ...
Leukemia 36 (4), 1066-1077, 2022
Mandates: US National Institutes of Health
Evaluation of sustained minimal residual disease negativity with daratumumab-combination regimens in relapsed and/or refractory multiple myeloma: analysis of POLLUX and CASTOR
H Avet-Loiseau, J San-Miguel, T Casneuf, S Iida, S Lonial, SZ Usmani, ...
Journal of Clinical Oncology 39 (10), 1139-1149, 2021
Mandates: US National Institutes of Health
Overall survival with daratumumab, lenalidomide, and dexamethasone in previously treated multiple myeloma (POLLUX): a randomized, open-label, phase III trial
MA Dimopoulos, A Oriol, H Nahi, J San-Miguel, NJ Bahlis, SZ Usmani, ...
Journal of Clinical Oncology 41 (8), 1590-1599, 2023
Mandates: US National Institutes of Health
Long term follow‐up data and health‐related quality of life in frontline therapy of fit patients treated with FCR versus BR (CLL10 trial of the GCLLSG)
N Kutsch, J Bahlo, S Robrecht, J Franklin, C Zhang, C Maurer, N De Silva, ...
Hemasphere 4 (1), e336, 2020
Mandates: Federal Ministry of Education and Research, Germany
Insights on multiple myeloma treatment strategies
MV Mateos, H Ludwig, A Bazarbachi, M Beksac, J Bladé, M Boccadoro, ...
Hemasphere 3 (1), e163, 2019
Mandates: National Institute for Health Research, UK
Extracellular vesicles isolated from plasma of multiple myeloma patients treated with daratumumab express CD38, PD-L1, and the complement inhibitory proteins CD55 and CD59
K Brennan, KF Iversen, A Blanco-Fernández, T Lund, T Plesner, ...
Cells 11 (21), 3365, 2022
Mandates: Health Research Board, Ireland, Science Foundation Ireland, Wellcome Trust
Publication and funding information is determined automatically by a computer program